General Information

CRO SPLENDID LAB PVT. LTD. from India has been added to ChemWhat’s Unreliable Entity List (UEL) due to a discrepancy between the quality of the sold impurity reference substance and its structure described in the provided test report. The company lacks internal quality control and retesting capabilities, and has refused to issue refunds or engage in further communication, resulting in significant losses for the pharmaceutical research and development company involved.

Company Information

Bank Information

Formal Assessment: CRO Splendid Lab Pvt. Ltd. – Systematic Deficiencies in Quality Management and Commercial Integrity

During customers’ collaboration with CRO Splendid Lab Pvt. Ltd. regarding impurity samples and subsequent quality verification processes, the company has demonstrated conduct severely inconsistent with its professional standing, revealing systemic issues in quality control, customer service, and commercial integrity across multiple operational areas.

Whilst the company is capable of providing analytical spectra and testing reports for samples, the reliability of such documentation has been fundamentally called into question during practical application. When customers raise specific queries regarding report content based on independent testing results, the company has proven unable to provide technical support or data verification, nor offer reasonable explanations for critical product quality attributes. This indicates significant deficiencies in their quality management system, suggesting that related documentation may be merely procedural, lacking effective process control.

Of particular concern is the company’s complete lack of response to reasonable refund requests from customers when product quality fails to align with testing reports, insisting solely on product replacement. However, given the company’s persistent failure to provide any technical clarification regarding customer concerns, replacement products cannot be guaranteed to meet quality standards, thereby failing to address customers’ fundamental concerns.

It should be specifically noted that the company’s legal representative and external liaison, Mr. Abhay Gandhi, as the directly responsible party, has demonstrated neither the requisite professional competence to address customer quality concerns nor taken commercial-level initiative to resolve issues. That the company’s representative exhibits such deficiencies further reflects the organisation’s overall lack of professional capability and absence of managerial accountability, rendering it unsuitable as a trustworthy business partner.

In conclusion, CRO Splendid Lab Pvt. Ltd. exhibits systemic deficiencies across quality management systems, customer response mechanisms, commercial reputation, and internal responsibility implementation. Their conduct extends beyond typical service oversights, constituting clear collaborative risks.

Therefore, ChemWhat formally advises all parties currently engaged in business relationships or planning collaboration with this entity to conduct thorough and prudent assessments of the significant uncertainties regarding the company’s quality control and contract fulfilment capabilities. Particular attention should be paid to the company’s demonstrated passive attitude and capability deficiencies in problem response and solution implementation. We strongly advise against advance payment arrangements in any collaboration, in order to substantially mitigate financial and delivery risks.